ID

44356

Descrição

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT02288208

Link

https://clinicaltrials.gov/show/NCT02288208

Palavras-chave

Versões (2)
  1. 28/01/2020 28/01/2020 -
  2. 20/09/2021 20/09/2021 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

20 de setembro de 2021

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Hepatitis B NCT02288208

Inglês

Eligibility Hepatitis B NCT02288208

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented history of chronic hepatitis b infection currently being treated with tenofovir or entecavir for at least 3 months
Descrição

Hepatitis B, Chronic | Tenofovir | entecavir

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0524909
UMLS CUI [2]
C0384228
UMLS CUI [3]
C0971023
measurable titer of hbsag
Descrição

Hepatitis B Surface Antigens Titer Measurable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C0475208
UMLS CUI [1,3]
C1513040
hbv dna level < 2 log copies/ml or 10² copies/ml
Descrição

Hepatitis B DNA Measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3641250
no more than child-pugh score of 5 plus a valid fibroscan® of at least 10 readings with a median score of <7 and interquartile range of < 30%
Descrição

Child-Pugh Clinical Classification | Fibroscan | Score Median | Interquartile Range

Tipo de dados

boolean

Alias
UMLS CUI [1]
C4050412
UMLS CUI [2]
C4522043
UMLS CUI [3,1]
C0449820
UMLS CUI [3,2]
C2939193
UMLS CUI [4]
C1711350
adequate liver function, aspartate ast and alt ≤2 x uln
Descrição

Liver function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
adequate renal function as evidenced by creatinine ≤2 mg/dl
Descrição

Renal function | Creatinine measurement, serum

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
participation in any interventional study within 4 weeks prior to screening
Descrição

Study Subject Participation Status | Interventional Study

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C3274035
known hiv infection, hepatitis c, or other significant hepatic disorder including cirrhosis (child-pugh class b or c)
Descrição

HIV Infection | Hepatitis C | Liver disease | Liver Cirrhosis Child-Pugh Classification

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0023895
UMLS CUI [4,1]
C0023890
UMLS CUI [4,2]
C4050412
serious illness or autoimmune disease or other known liver disease
Descrição

Illness Serious | Autoimmune Disease | Liver diseases

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0004364
UMLS CUI [3]
C0023895
uncontrolled hypertension
Descrição

Uncontrolled hypertension

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1868885
impaired cardiac function, uncontrolled cardiac arrhythmias despite medications, or clinically significant cardiac disease
Descrição

Decreased cardiac function | Cardiac Arrhythmia Uncontrolled | Pharmacotherapy | Heart Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232166
UMLS CUI [2,1]
C0003811
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0013216
UMLS CUI [4]
C0018799
currently breast feeding, pregnant or planning on becoming pregnant
Descrição

Breast Feeding | Pregnancy | Pregnancy, Planned

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0032992
known allergy or hypersensitivity to any of the formulation components of birinapant or placebo, including citric acid
Descrição

Hypersensitivity Birinapant Component | Hypersensitivity Placebo Component | Hypersensitivity Citric Acid

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3658709
UMLS CUI [1,3]
C1705248
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0032042
UMLS CUI [2,3]
C1705248
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0055819
history of cranial nerve palsy
Descrição

Cranial nerve palsy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151311
current treatment with anti-tnf therapies or has received treatment with anti-tnf therapies within the last 6 months
Descrição

Anti-tumor necrosis factor therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0281481
use of non-steroidal anti-inflammatory drugs
Descrição

Anti-Inflammatory Agents, Non-Steroidal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003211
Voltar ao início da página

Similar models

Eligibility Hepatitis B NCT02288208

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B, Chronic | Tenofovir | entecavir
Item
documented history of chronic hepatitis b infection currently being treated with tenofovir or entecavir for at least 3 months
boolean
C0524909 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0971023 (UMLS CUI [3])
Hepatitis B Surface Antigens Titer Measurable
Item
measurable titer of hbsag
boolean
C0019168 (UMLS CUI [1,1])
C0475208 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
Hepatitis B DNA Measurement
Item
hbv dna level < 2 log copies/ml or 10² copies/ml
boolean
C3641250 (UMLS CUI [1])
Child-Pugh Clinical Classification | Fibroscan | Score Median | Interquartile Range
Item
no more than child-pugh score of 5 plus a valid fibroscan® of at least 10 readings with a median score of <7 and interquartile range of < 30%
boolean
C4050412 (UMLS CUI [1])
C4522043 (UMLS CUI [2])
C0449820 (UMLS CUI [3,1])
C2939193 (UMLS CUI [3,2])
C1711350 (UMLS CUI [4])
Liver function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
adequate liver function, aspartate ast and alt ≤2 x uln
boolean
C0232741 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Renal function | Creatinine measurement, serum
Item
adequate renal function as evidenced by creatinine ≤2 mg/dl
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status | Interventional Study
Item
participation in any interventional study within 4 weeks prior to screening
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
HIV Infection | Hepatitis C | Liver disease | Liver Cirrhosis Child-Pugh Classification
Item
known hiv infection, hepatitis c, or other significant hepatic disorder including cirrhosis (child-pugh class b or c)
boolean
C0019693 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0023890 (UMLS CUI [4,1])
C4050412 (UMLS CUI [4,2])
Illness Serious | Autoimmune Disease | Liver diseases
Item
serious illness or autoimmune disease or other known liver disease
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0004364 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Decreased cardiac function | Cardiac Arrhythmia Uncontrolled | Pharmacotherapy | Heart Disease
Item
impaired cardiac function, uncontrolled cardiac arrhythmias despite medications, or clinically significant cardiac disease
boolean
C0232166 (UMLS CUI [1])
C0003811 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
Breast Feeding | Pregnancy | Pregnancy, Planned
Item
currently breast feeding, pregnant or planning on becoming pregnant
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Hypersensitivity Birinapant Component | Hypersensitivity Placebo Component | Hypersensitivity Citric Acid
Item
known allergy or hypersensitivity to any of the formulation components of birinapant or placebo, including citric acid
boolean
C0020517 (UMLS CUI [1,1])
C3658709 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0032042 (UMLS CUI [2,2])
C1705248 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0055819 (UMLS CUI [3,2])
Cranial nerve palsy
Item
history of cranial nerve palsy
boolean
C0151311 (UMLS CUI [1])
Anti-tumor necrosis factor therapy
Item
current treatment with anti-tnf therapies or has received treatment with anti-tnf therapies within the last 6 months
boolean
C0281481 (UMLS CUI [1])
Anti-Inflammatory Agents, Non-Steroidal
Item
use of non-steroidal anti-inflammatory drugs
boolean
C0003211 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial